Skip to main content
. Author manuscript; available in PMC: 2019 Jul 23.
Published in final edited form as: Clin Chem. 2019 Jan 15;65(3):406–418. doi: 10.1373/clinchem.2018.288092

Table 6.

Reclassification of participants in the combined development and validation data sets using eGFRmet vs eGFRcr according to mGFR greater and lower than 60 mL/min/1.73 m2.

Total group Subgroup with mGFR
<60 mL/min/1.73 m2
Subgroup with mGFR
≥60 mL/min/1.73 m2



eGFRcr range,
mL/min/1.73 m2
n Total
reclassified
n (%)
n Correctly
reclassifieda
n (%)
Incorrectly
reclassifiedb
n (%)
Net
difference,
%
n Correctly
reclassifiedb
n (%)
Incorrectly
reclassifieda
n (%)
Net
difference,
%
Overall NRIc
(95% Cl)
Overall 2424 349 (14.4) 1,367 72 (5.3) 72 (5.3) 0 1057 132 (12.5) 73 (6.9)    5.6 5.6 (2.4–8.7)
30–89 1864 347 (18.6)   942 72(7.6) 72 (7.6) 0   922 132 (14.3) 71 (7.7)    6.6 6.6 (2.7–10.5)
45–74 1123 322 (28.7)   495 68(13.7) 68 (13.7) 0   628 127 (20.2) 59 (9.4) 10.8 10.8 (4.5–17.1)
60–74   546 127 (23.3)   118 68(57.6) NAd NA   428 NA 59 (13.8) NA NA
45–59   577 195 (33.8)   377 NA 68 (18.0) NA   200 127 (63.5) NA NA NA
a

eGFRcr ≥ 60 and eGFRmet < 60.

b

eGFRcr < 60 and eGFRmet ≥ 60.

c

Values for NRI can be from −200 to 200. P < 0.001 for all.

d

NA, not applicable; NRI, net reclassification index.